Deliang Shen

4.1k total citations · 2 hit papers
70 papers, 3.0k citations indexed

About

Deliang Shen is a scholar working on Surgery, Molecular Biology and Biomaterials. According to data from OpenAlex, Deliang Shen has authored 70 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 24 papers in Molecular Biology and 16 papers in Biomaterials. Recurrent topics in Deliang Shen's work include Tissue Engineering and Regenerative Medicine (24 papers), Electrospun Nanofibers in Biomedical Applications (16 papers) and Extracellular vesicles in disease (9 papers). Deliang Shen is often cited by papers focused on Tissue Engineering and Regenerative Medicine (24 papers), Electrospun Nanofibers in Biomedical Applications (16 papers) and Extracellular vesicles in disease (9 papers). Deliang Shen collaborates with scholars based in China, United States and Japan. Deliang Shen's co-authors include Ke Cheng, Shiqi Hu, Adam C. Vandergriff, Ke Huang, Jinying Zhang, Michael Taylor Hensley, Eduardo Marbán, Zhenhua Li, Teng Su and Ke Cheng and has published in prestigious journals such as Circulation, Nature Communications and Nano Letters.

In The Last Decade

Deliang Shen

70 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs

2020 325 citations Li Qiao, Shiqi Hu et al. Theranostics profile →
Exosome-eluting stents for vascular healing after ischaemic injury

2021 161 citations Shiqi Hu, Zhenhua Li et al. Nature Biomedical Engineering profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deliang Shen China	27	1.5k	1.1k	851	681	520	70	3.0k
Junnan Tang China	30	1.3k 0.8×	1.0k 0.9×	799 0.9×	846 1.2×	410 0.8×	104	3.3k
Santiago Roura Spain	33	1.9k 1.3×	1.2k 1.0×	658 0.8×	369 0.5×	477 0.9×	97	3.5k
Carolina Gálvez‐Montón Spain	30	1.1k 0.7×	990 0.9×	623 0.7×	359 0.5×	386 0.7×	93	2.4k
Jhon Cores United States	20	1.4k 0.9×	596 0.5×	522 0.6×	529 0.8×	546 1.1×	27	2.4k
David W. Courtman Canada	31	981 0.6×	1.3k 1.2×	791 0.9×	412 0.6×	300 0.6×	74	3.6k
Ke Huang China	37	2.8k 1.8×	1.4k 1.2×	973 1.1×	864 1.3×	1.3k 2.5×	115	5.0k
Michael Taylor Hensley United States	20	954 0.6×	1.1k 1.0×	901 1.1×	597 0.9×	260 0.5×	28	2.2k
Vincent F. M. Segers Belgium	27	1.8k 1.2×	1.6k 1.4×	911 1.1×	383 0.6×	258 0.5×	60	3.8k
Thomas G. Caranasos United States	21	862 0.6×	875 0.8×	567 0.7×	493 0.7×	267 0.5×	77	2.2k
Adam C. Midgley China	33	1.2k 0.8×	850 0.8×	1.1k 1.3×	1.1k 1.6×	249 0.5×	88	3.6k

Countries citing papers authored by Deliang Shen

Since Specialization

Citations

This map shows the geographic impact of Deliang Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deliang Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deliang Shen more than expected).

Fields of papers citing papers by Deliang Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deliang Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deliang Shen. The network helps show where Deliang Shen may publish in the future.

Co-authorship network of co-authors of Deliang Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Deliang Shen. A scholar is included among the top collaborators of Deliang Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deliang Shen. Deliang Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiao, Zhentao, et al.. (2024). Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion Injury. Advanced Science. 11(42). e2406124–e2406124. 7 indexed citations

Li, Zhe, et al.. (2024). Apoptotic extracellular vesicles: mechanisms, applications, and therapeutic potential. 2(1). 4 indexed citations

Liu, Chuang, Jun Li, Deliang Shen, et al.. (2024). Standby extracorporeal membrane oxygenation: a better strategy for high-risk percutaneous coronary intervention. Frontiers in Medicine. 11. 1404479–1404479. 3 indexed citations

Shen, Deliang, et al.. (2024). Nanomedicines as Guardians of the Heart: Unleashing the Power of Antioxidants to Alleviate Myocardial Ischemic Injury. Theranostics. 14(13). 5336–5370. 3 indexed citations

Yang, Tingting, Nan Zhang, Yuanyuan Liu, et al.. (2024). Nanoplatelets modified with RVG for targeted delivery of miR-375 and temozolomide to enhance gliomas therapy. Journal of Nanobiotechnology. 22(1). 623–623. 4 indexed citations

Qiao, Zhentao, et al.. (2024). The association between triglyceride-glucose index and related parameters and risk of cardiovascular disease in American adults under different glucose metabolic states. Diabetology & Metabolic Syndrome. 16(1). 102–102. 15 indexed citations

Qiao, Zhentao, Bo Wang, Yi Zhang, et al.. (2022). Neutrophil membrane-camouflaged nanoparticles alleviate inflammation and promote angiogenesis in ischemic myocardial injury. Bioactive Materials. 23. 369–382. 42 indexed citations

Wang, Bo, Zhentao Qiao, Xinyue Cui, et al.. (2022). A Novel Compound, Tanshinol Borneol Ester, Ameliorates Pressure Overload-Induced Cardiac Hypertrophy by Inhibiting Oxidative Stress via the mTOR/β-TrCP/NRF2 Pathway. Frontiers in Pharmacology. 13. 830763–830763. 5 indexed citations

Hu, Shiqi, Zhenhua Li, Deliang Shen, et al.. (2021). Exosome-eluting stents for vascular healing after ischaemic injury. Nature Biomedical Engineering. 5(10). 1174–1188. 161 indexed citations breakdown →

10.

Qiao, Li, Shiqi Hu, Ke Huang, et al.. (2020). Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs. Theranostics. 10(8). 3474–3487. 325 indexed citations breakdown →

11.

Yue, Xiao-Ting, Jiacheng Guo, Jianchao Zhang, et al.. (2020). Evaluation of Mechanical Performances of Stents with 38 mm Length in Long Lesion. BioMed Research International. 2020(1). 2594161–2594161. 3 indexed citations

12.

Wang, Wenlong, et al.. (2018). Polyphenol epigallocatechin-3-gallate inhibits hypoxia/reoxygenation-induced H9C2 cell apoptosis. Minerva Medica. 109(2). 95–102. 10 indexed citations

13.

Vandergriff, Adam C., Ke Huang, Deliang Shen, et al.. (2018). Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. Theranostics. 8(7). 1869–1878. 311 indexed citations

14.

Liu, Cong-Lin, Junnan Tang, Zhaozhong Zhu, et al.. (2017). Interleukin-18, matrix metalloproteinase-22 and -29 are independent risk factors of human coronary heart disease. Journal of Zhejiang University SCIENCE B. 18(8). 685–695. 8 indexed citations

15.

Zhao, Xiaoyan, Xiaofang Wang, Ling Li, et al.. (2015). Effects of high glucose on human umbilical vein endothelial cell permeability and myosin light chain phosphorylation. Diabetology & Metabolic Syndrome. 7(1). 98–98. 26 indexed citations

16.

Vandergriff, Adam C., et al.. (2014). Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction. Biomaterials. 35(30). 8528–8539. 95 indexed citations

17.

Cheng, Ke, Konstantinos Malliaras, Rachel Smith, et al.. (2014). Human Cardiosphere-Derived Cells From Advanced Heart Failure Patients Exhibit Augmented Functional Potency in Myocardial Repair. JACC Heart Failure. 2(1). 49–61. 90 indexed citations

18.

Sun, Tongwen, Xiaojuan Zhang, Deliang Shen, et al.. (2014). Red Blood Cell Distribution Width and Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stenting Era: A Two-Year Cohort Study. PLoS ONE. 9(4). e94887–e94887. 27 indexed citations

19.

Shen, Deliang, Ke Cheng, & Eduardo Marbán. (2012). Dose‐dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. Journal of Cellular and Molecular Medicine. 16(9). 2112–2116. 65 indexed citations

20.

Xie, Yucai, Ke Cheng, Hee Cheol Cho, et al.. (2011). Abstract 16688: Human Cardiosphere-Derived Cells Stimulate Cardiomyocyte Proliferation in vivo and in Co-Culture. Circulation. 124. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact